top of page

Disease burden.

Contemporary multinational studies to understand the current burden, risks and costs of a disease, e.g., chronic kidney disease, heart failure, type 1 diabetes and type 2 diabetes. 

Real world evidence research prevalence

Prevalence

In aging populations and changes in diagnostic traditions, contemporary prevalence is important for planning of health care

Patient characteristics

Patient characteristics increase the understanding of the burden of risk factors/comorbidity, potential subgroups and treatments.

Population real world evidence research
Risks real world evidence research

Outcome Risks

In addition to the prevalent disease burden, risks need to be estimated to increase the disease awareness and the potential burden on the health care system going forward.

Health care costs

Following the risks in large disease populations, the attributed health care costs are important, to understand which diseases drive health care utilization and the potential size. Countrywise investigations are important  since health care costs are dependent on the organization of the health care system.​​​​​​​

Costs real world evidence research
bottom of page